Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile
Susan C. Modesitt, MD

@susanmodesitt

Professor and Director, Gynecologic Oncology, Emory University; Editor-in-Chief, Gynecologic Oncology Reports @gynoncjnls

ID: 1254965336

calendar_today09-03-2013 17:45:35

109 Tweet

942 Followers

243 Following

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

Dr. Straughn is an amazing physician, deputy editor AND a leader in quality research. Check out his editorial and two important QI papers in GYN Onc reports. @GynOncJnls SGO UAB OB/GYN Residency Program

Deborah W. Bruner (@deborahwbruner1) 's Twitter Profile Photo

Team pub led by Emory Nursing postdoc Zahra A. Barandouzi etal on Assoc's Betwn Social Determinants of Health (SDOH) & Psychoneurologic Symptoms (PNS) in Women w Gyne #Cancers: Mar 2023, ONF, 50(2) Results: low educ, income, nemployment &disadvantaged neighborhoods associated w more PNS

Team pub led by <a href="/EmoryNursing/">Emory Nursing</a> postdoc <a href="/ZahraAB20/">Zahra A. Barandouzi</a> etal on Assoc's Betwn Social Determinants of Health (SDOH) &amp; Psychoneurologic Symptoms (PNS) in Women w Gyne #Cancers: Mar 2023, ONF, 50(2)  Results: low educ, income, nemployment &amp;disadvantaged neighborhoods associated w more PNS
Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

Preventing future ovarian cancer can be a team effort. All surgeons can help by considering opportunistic salpingectomy at the time of any abdominal surgery. @GynOncJnls SGO nam11.safelinks.protection.outlook.com/?url=https%3A%…

@GynOncJnls (@gynoncjnls) 's Twitter Profile Photo

Free Article Publishing Charge (APC) alert 🔔🚨 Follow @GynOncJnls during the SGO Annual Meeting #SGO2023 #SGOMtg and have a chance to win an APC waiver for #GynOncReports ☀️ 🏝️ #Tampa

Free Article Publishing Charge (APC) alert 🔔🚨 Follow <a href="/gynoncjnls/">@GynOncJnls</a> during the <a href="/SGO_org/">SGO</a> Annual Meeting #SGO2023 #SGOMtg and have a chance to win an APC waiver for #GynOncReports ☀️ 🏝️ #Tampa
David OMalley (@omalleygynonc) 's Twitter Profile Photo

Very low % Serous carcinomas in early stage trials: ACTION (35%), ICON1 (30%), GOG 157 (23%). Underestimating the recurrence rate???? doi.org/10.1016/j.gore…

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

Thank you Dr. Manning-Geist for this commentary. Ovarian cancer rates have been dropping in the US; likely due in part to increasing use of risk reducing surgeries in genetically high risk women. Prevention is FAR better than early cancer detection. SGO @GynOncJnls

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

Amazing year for our specialty and our journals to be able to share the knowledge that will continue to improve our patients lives. Thank you for following!

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

Thrilled for our first impact factor but, more importantly, thrilled at the growth and progress of the journal to immediately publish work that improves care for gynecologic oncology patients. Kudos to our authors, reviewers and editorial team. @GynOncJnls SGO

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

So appreciative of both of our amazing editorial teams’ ability to quickly publish research that matters for our patients and our society. Happy Holidays! @GynOncJnls SGO

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

Dr. Hutchcraft (Gynecologic Oncology reports editorial fellow) has been doing amazing tweets to highlight the incredible work being presented at Winter SGO. @GynOncJnls SGO

Susan C. Modesitt, MD (@susanmodesitt) 's Twitter Profile Photo

So proud of our journals and the amazing work being done to advance care for gynecologic cancer patients. Hitting the 3K milestone during GCAM, even better! SGO David Cohn, MD, MBA